MarzNC
Well-known member
- Joined
- Jul 18, 2020
What I did professionally was work at a company in the Biostatistics Dept. that did clinical trials for drug development. I worked on more than one project that went thru FDA approval. Several of my Biostatistics graduate school schoolmates went to work for the FDA. I don't have any experience with a vaccine protocol though.. . . but the long term affects of a vaccine rushed to market, not so much for me as I'm almost as old and ornery as you but for my kids & future grandkids
That said, I don't have a sense that the actual clinical trials in terms of patient recruitment and follow up was rushed. At least not by the companies based in the U.S. or western Europe. Those regulatory agencies will prioritize review of any reports submitted for vaccine trials. Each country does their own review. Ironically it was the countries with too much community spread that allowed the trials to finish the efficacy phases sooner rather than later. My sense is that finding willing volunteers wasn't that difficult in more than one country. Granted you can't have safety evaluations for more than about 6 months for a novel disease like COVID-19. I don't know how long is normally required for a vaccine. I think the followup is at least 2 years for the on-going clinical trials for the current vaccine candidates.
I think if you read the adverse effect list for any drug, there are more potential complications than for vaccines in general.